Gastrointestinal Cancer News

This year’s ASCO Annual Meeting, held June 2-6 in Chicago, featured the theme “Making a Difference in Cancer Care With You.”

Elderly patients with early-stage esophageal cancer who received treatment achieved 5-year OS more often than those under observation, according to a retrospective study published in Journal of Thoracic Oncology.

Computerized tomography and magnetic resonance imaging pelvic scans resulted in limited new findings of lesions or metastatic disease in patients with hepatocellular carcinoma, researchers reported in a recently published study.

Liver cancer mortality rates are expected to increase in the coming decades and disparities in occurrence by race, ethnicity, sex and state location in the U.S. continue to persist, according to a recently published study.

Case Comprehensive Cancer Center and Case Western Reserve University School of Medicine received a $6 million, 5-year grant from the National Cancer Institute to continue research of Barrett’s esophagus, according to a press release.

Women who used oral contraceptives did not demonstrate increased long-term cancer risk, according to results of the Royal College of General Practitioner’s Oral Contraception Study.

More than 2 billion children and adults globally were affected by excess weight in 2015, and the percentage of people dying from health conditions stemming from being overweight or obese is rising, according to findings published in The New England Journal of Medicine.

CHICAGO — Jarushka Naidoo, MBBCh, spoke with HemOnc Today at the ASCO Annual Meeting about the Institute for Clinical Immuno-Oncology.

The FDA denied approval of Coherus BioSciences’ biologics license application for CHS-1701, a proposed biosimilar for pegfilgrastim.

President Donald J. Trump selected Norman E. “Ned” Sharpless, MD, to serve as director of NCI.